Why Working with a Full-Service Clinical Research Company Is Invaluable

By

As a biotechnology or a pharmaceutical company, your on-site capabilities for clinical development may be limited. From small firms to large firms, there are always gaps that need to be bridged. Whether it’s regulatory compliance hurdles or challenges in early clinical development, your company may encounter significant roadblocks that could prevent continued work on any given project. Therefore, you’re faced with a choice: continue internally—even if you’re not fully equipped to do so—or partner with a contract research organization. Electing not to work with a CRO can come with many pitfalls that may ultimately cause delay to your drug development. Here are the reasons why partnering with a CRO for your next drug development project is invaluable.


The On-Going Challenge of Regulatory Compliance

Throughout the drug development cycle, your organization may find it difficult to navigate certain aspects. One of those areas could be regulatory requirements during each stage of development. With governmental oversight, laws, and regulations continually evolving, it can be challenging to keep up to date on regulatory requirements. Working with a CRO helps overcome this challenge, particularly when moving from one phase of development to the next. This is especially true for initiating your first in human clinical trials, which requires the submission of an investigational new drug application (IND).

Cost and Resource Management

Partnering with a CRO is the most cost-effective solution when managing your drug development project. From regulatory paperwork to conducting clinical trials, a full-service CRO will have the scientific and operational resources to make it all happen. A pharmaceutical or biotechnology company may not have the facilities, staff, testing equipment, access to a robust participant database and other specific resources to conduct certain clinical trials. Still, the question of whether or not to invest in these resources internally may arise. However, if your company lacks clinical research facilities, it can prove costly to develop an in-house solution. Partnering with a clinical research organization helps mitigate many of these costs, allowing you to retain your focus without spreading resources too thin, not to mention handling logistics.

Personnel and Participants

One of the biggest reasons to work with a CRO comes down to people. This means for staff to manage all aspects of the clinical trials and to ensure the recruitment of participants to participate on studies. Working with a trusted CRO provides solutions for these needs. The CRO should have experts to help facilitate and guide your company in the process. The right CRO will also have access to a robust participant database to ensure recruitment and retention during your trials. Finding participants for your trials can prove to be time-consuming and costly, so your partnership with a dedicated CRO is vital. In short, a CRO can help connect you with the expert personnel and participants you need to move forward with your trials, netting you invaluable data necessary to move to the phases of your drug development program.

 About Altasciences

 With over 25 years of research experience, Altasciences is a mid-sized drug development solution company. Thanks to their innovative approach, Altasciences has built a foundation that biotechnology and pharmaceutical companies have come to rely on. With tailor-made program roadmaps, clients are guided through the drug development process, from lead candidate selection to clinical proof of concept, and beyond. Altasciences possesses expertise in a wide range of study types and therapeutic indications in early clinical development, with key experience in first in human clinic trials, CNS clinical trials and ethnobridging. Altasciences maintains several phase 1 clinical trial units across North America, making their services and resource base accessible. Those resources include a highly trained and experienced staff, along with access to over 580 beds and more than 400,000 potential participants in their database. For sponsors in need of dedicated and integrated CRO/CDMO services, Altasciences is the perfect choice for drug development.

 Learn more about the extensive resource base offered by Altasciences at https://www.altasciences.com/


Comments

Post a Comment

Popular posts from this blog

4 Things to Know About Driving Simulation Clinical Trials

By
Image
If you are performing CNS clinical trials , there is a good chance that you will need to determine the impact of the medication on a person’s driving ability. It’s common to test for this, and several methods have been developed over the years. If this is your first CNS trial, you may need to know about driving simulation trials and whether you should partner with a contract research organization (CRO) to perform the simulation. Here are some things you should know. Why Should You Add Driving Ability Tests? Preventing traffic accidents resulting from drug impairment is an important public health priority. This is where clinical trials come into the picture. Depending on where you hope to get drug authorization, you may need to perform driving simulation clinical trials. Countries like the United States might have restrictions on CNS drugs that could potentially impair driving. At the same time, Japan prohibits driving while on any medications known to affect the CNS, regardless of whe...
Read more

How to Strengthen Recruiting Methods for Your Clinical Trials

By
Image
Recruiting clinical trial participants is hugely influential for the entirety of your drug trial. Entering the recruitment phase of any trial might seem straightforward on paper, but the reality can be very different. The recruitment process can directly impact your trial timeline, as well as the proposed budget of the trial. It influences the tools and resources required to complete the trial and, ultimately, the results of the trial. When you’re conducting research on new pharmaceutical drugs, the integrity of the data is paramount. When deciding on the details for your trial and which Phase 1 clinical trial units to use recruitment strategies that will maintain your timeline, budget, and more, are essential considerations. Here’s what those strategies can look like. Establish a Clear Picture of Potential Participants When recruiting participants, numerous variables need to be addressed ahead of the clinical trial and ahead of the recruitment process itself. Your ideal candidate m...
Read more

4 Reasons to Partner with a CRO for Driving Simulation Studies During Drug Development

By
Image
In 2017, the FDA declared that driving simulation studies are required for all drugs that may affect cognition. During early clinical development , your organization must determine whether a driving simulation test is needed for regulatory approval. If so, it’s a good idea to partner with a contract research organization that has the experience and resources necessary to carry out the testing. Here are four reasons you should consider partnering with a CRO to conduct driving simulation tests. Recruiting Database Speeds Up Recruiting An experienced CRO will have access to an extensive database of potential participants for your study, from healthy normal volunteers to patients and special populations. These potential participants may have the necessary qualifications for your study or will be easier to screen than if you simply marketed the study to the general population. The CRO can perform the screening process, helping the study get started as early as possible. A recruiting datab...
Read more